Why the study?
Several studies investigated the relationship between psoriasis and epicardial fat tissue, but each had relatively small patient numbers.
Does psoriasis associate with increased epicardial fat tissue compared to controls without psoriasis?
Population
731 patients from 5 trials including psoriasis and control groups
Comparison
Patients with psoriasis vs control subjects without psoriasis
Design
Systematic review and meta-analysis of controlled trials
Key result
Patients with psoriasis had significantly higher epicardial fat tissue compared to control subjects without psoriasis (SMD 0.86).
Authors
Loading...
Psoriasis patients show higher epicardial fat; confirms association across pooled studies but leaves causal cardiovascular implications open for prospective trials.
Meta-Analysis (n=731)
Does psoriasis associate with increased epicardial fat tissue compared to controls without psoriasis?
Standardized Mean Difference: 0.86 (95% CI 0.27–1.46)
p-value: p=0.004
Patients with psoriasis have significantly higher epicardial fat tissue compared to controls, which may contribute to their increased cardiovascular risk.
Wang et al. (2016) conducted a meta-analysis in Psoriasis (n=731). Psoriasis vs. Control group without psoriasis was evaluated on Epicardial fat tissue (EFT) (SMD 0.86, 95% CI 0.27-1.46, p=0.004). Patients with psoriasis had significantly higher epicardial fat tissue compared to control subjects without psoriasis (SMD 0.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: